Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2015, Article ID 286380, 4 pages
http://dx.doi.org/10.1155/2015/286380
Case Report

Does the Maternal Serum IgG Level during Pregnancy in Primary Antibody Deficiency Influence the IgG Level in the Newborn?

1Epsom and St Helier University Hospitals NHS Trust, Carshalton, Surrey SM5 1AA, UK
2St Georges University of London, London SW17 0RE, UK
3St George’s University Hospitals NHS Foundation Trust, Tooting, London SW17 0QT, UK

Received 18 June 2015; Revised 17 August 2015; Accepted 18 August 2015

Academic Editor: Alessandro Plebani

Copyright © 2015 Vasantha Nagendran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Palmeira, C. Quinello, A. L. Silveira-Lessa, C. A. Zago, and M. Carneiro-Sampaio, “IgG placental transfer in healthy and pathological pregnancies,” Clinical and Developmental Immunology, vol. 2012, Article ID 985646, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. E. Simister, “Placental transport of immunoglobulin G,” Vaccine, vol. 21, no. 24, pp. 3365–3369, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. T. Costa Carvalho, M. M. Carneiro-Sampaio, D. Solé, C. Naspitz, L. E. Leiva, and R. U. Sorensen, “Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 1, pp. 50–54, 1999. View at Google Scholar · View at Scopus
  4. F. M. Schaffer and J. A. Newton, “Intravenous gamma globulin administration to common variable immunodeficient women during pregnancy: case report and review of the literature,” Journal of Perinatology, vol. 14, no. 2, pp. 114–117, 1994. View at Google Scholar · View at Scopus
  5. H. Osada, Y. Morikawa, T. Nishiwaki, and S. Sekiya, “Intravenous immunoglobulin replacement therapy for common variable immunodeficiency during pregnancy,” Archives of Gynecology and Obstetrics, vol. 258, no. 3, pp. 155–159, 1996. View at Publisher · View at Google Scholar
  6. P. Palmeira, B. T. Costa-Carvalho, C. Arslanian, G. N. Pontes, A. T. Nagao, and M. M. S. Carneiro-Sampaio, “Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin,” Pediatric Allergy and Immunology, vol. 20, no. 6, pp. 528–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gardulf, E. Anderson, M. Lindqvist, S. Hansen, and R. Gustafson, “Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women,” Journal of Clinical Immunology, vol. 21, no. 2, pp. 150–154, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Vitoratos, P. Bakas, H. Kalampani, and G. Creatsas, “Maternal common variable immunodeficiency and pregnancy,” Journal of Obstetrics & Gynaecology, vol. 19, no. 6, pp. 654–655, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Cherian, “WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva,” Vaccine, vol. 25, no. 36, pp. 6557–6564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, “Recommendation for the production and control of pneumococcal conjugate vaccines,” WHO Technical Report Series 927, 2005. View at Google Scholar
  11. H. Kayhty, H. Peltola, V. Karanko, and P. H. Makela, “The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b,” The Journal of Infectious Diseases, vol. 147, no. 6, pp. 1100–1101, 1983. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Booy, S. J. M. Aitken, S. Taylor et al., “Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age,” The Lancet, vol. 339, no. 8792, pp. 507–510, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. J. W. Smith, “Diptheria and tetanus toxoids,” British Medical Bulletin, vol. 25, no. 2, pp. 177–182, 1969. View at Google Scholar
  14. A. P. Machado, G. Gonçalves, H. Barros, and M. S. Nascimento, “Mother-child transmission of immunoglobulins G,” Acta Medica Portuguesa, vol. 8, no. 2, pp. 81–85, 1995. View at Google Scholar · View at Scopus
  15. P. F. Kohler and R. S. Farr, “Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport,” Nature, vol. 210, no. 5040, pp. 1070–1071, 1966. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Toivanen, R. Mäntyjärvi, and T. Hirvonen, “Maternal antibodies in human foetal sera at different stages of gestation,” Immunology, vol. 15, no. 3, pp. 395–403, 1968. View at Google Scholar · View at Scopus
  17. R. Mäntyjärvi, T. Hirvonen, and P. Toivanen, “Maternal antibodies in human neonatal sera,” Immunology, vol. 18, no. 3, pp. 449–451, 1970. View at Google Scholar · View at Scopus
  18. M. I. de Moraes-Pinto, A. C. M. Almeida, G. Kenj et al., “Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection,” The Journal of Infectious Diseases, vol. 173, no. 5, pp. 1077–1084, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Jones, L. Pollock, S. M. Barnett, A. Battersby, and B. Kampmann, “Specific antibodies against vaccine-preventable infections: a mother–infant cohort study,” BMJ Open, vol. 3, no. 4, Article ID e002473, 2013. View at Publisher · View at Google Scholar · View at Scopus